Sandbox:Hannan: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 67: Line 67:
* Higher cardiovascular and cerebrovascular morbidity
* Higher cardiovascular and cerebrovascular morbidity
|-
|-
|Cortisol<ref name="pmid26867466">{{cite journal |vauthors=Park JJ, Park BK, Kim CK |title=Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses |journal=Br J Radiol |volume=89 |issue=1062 |pages=20151018 |date=June 2016 |pmid=26867466 |pmc=5258164 |doi=10.1259/bjr.20151018 |url=}}</ref>
|Cortisol
|
|
* Weight gain
* Weight gain
Line 132: Line 132:
* Amenorrhea
* Amenorrhea
* Precocious puberty
* Precocious puberty
* Testicular atrophy & diminished libido (male)
|
|
* Clitorimegaly
* Clitorimegaly
* Male pattern baldness
* Male pattern baldness
* Resistant hypertension
* Resistant hypertension
* Gynecomastia
|
|
* ↑ Serum testosterone
* ↑ Serum androstenedione
* ↑ Serum dehydroepiandrosterone sulfate (DHEA-S)
* ↑ urine 17-ketosteroids
* ↑ plasma and urine estrogens
*
*
|
|
*
|
|
* Well-defined
* Solid mass
* Homogeneous enhancement (CT contrast)
* Hyperintense on in-phase and hypointense on oppose-phase (MRI)
|
|
|
|

Revision as of 18:56, 31 January 2019

Cortex Product Clinical manifestations Dianosis Gold

standard

Other features
Symptoms Signs Blood & Urine Histopathological Imaging Others
Adenoma Aldosterone
  • Headache
  • Vision problems
  • Muscle cramps
  • Muscle weakness & cramps
  • Numbness
  • Temporary paralysis
  • Polyuria and polydipsia
  • Hypertension
  • Refractory hypertension
  • Hypokalemia
  • Alkalosis
  • ↑ Plasma aldosterone
  • ↓ Plasma Renin
  • ↑ ARR
  • Single or multiple nodules
  • Encapsulated
  • Abundant clear cytoplasm
  • Uniforming nuclei
  • Histopathology may resemble:
    • ZF (large, lipid-laden clear cells)
    • ZG (small, compact cells with moderate amount of lipid)
    • ZR (lipid-sparse cytoplasm)
  • Adrenal mass or nodule
  • Unilateral or bilateral adrenal atrophy
  • Hypodense mass (CT)
  • Iso and low FDG uptake compared with liver (FDG PET/CT)
  • Hyperintense on in-phase and hypointense on oppose-phase (MRI)
  • Fludrocortisone Suppression Testing
  • Oral Sodium Loading
  • Saline Infusion Testing
  • Captopril test
  • Adrenal venous sampling
  • Posture test
  • Genetic testing
  • Immunohistochemical staining
  • Fludrocortisone Suppression Testing
  • Glucocorticoid-Remediable Aldosteronism responds to glucocorticoids
  • Higher cardiovascular and cerebrovascular morbidity
Cortisol
  • Weight gain
  • Growth retardation
  • Headaches
  • Amenorrhea
  • Virilization (rare)
  • Acne
  • Violaceous striae
  • Acanthosis nigricans
  • Sleep disruption
  • Mental changes
  • Muscular weakneness
  • Hypertension
  • Hirsutism
  • Hypogonadism
  • Growth retardation
  • Facial plethora
  • Acne
  • Striae
  • Bruising
  • Acanthosis nigricans
  • Mental changes
  • Muscular weakneness
  • ↑ Plasma cortisol
  • ↑ 24 Hour urinary cortisol
  • ↓ or inappropriately normal plasma ACTH
  • ↑ Blood glucose
  • Yellow fat
  • Brown discoloration
  • Large cells with increased lipid contetnt (zona fasciculata)
  • May contain pigment (lipofuscin)
  • Adjacent atrophied cells
  • Hemorrhage and calcification (Pre-malignant lesions)
  • Adrenal mass or nodule
  • Unilateral or bilateral adrenal atrophy
  • ↑ Fat
  • Hypodense mass (CT)
  • Iso and low FDG uptake compared with liver (FDG PET/CT)
  • Hyperintense on in-phase and hypointense on oppose-phase (MRI)
  • Diurnal plasma cortisol variation
  • Low dose and high dose dexamethasone suppression test
  • Dexamethasone-CRH test
  • Adrenal venous sampling
  • Genetic testing
  • Immunohistochemical staining
  • Dual-energy X-ray absorptiometry
  • N/A
  • Associated with Carney complex
  • Associated with MEN-1
  • Plasma levels of cortisol and ACTH may show false positive and false negative results due to normal diurnal hormonal variation
Androgens
  • Hirsutism
  • Virilization
  • Amenorrhea
  • Precocious puberty
  • Testicular atrophy & diminished libido (male)
  • Clitorimegaly
  • Male pattern baldness
  • Resistant hypertension
  • Gynecomastia
  • ↑ Serum testosterone
  • ↑ Serum androstenedione
  • ↑ Serum dehydroepiandrosterone sulfate (DHEA-S)
  • ↑ urine 17-ketosteroids
  • ↑ plasma and urine estrogens
  • Well-defined
  • Solid mass
  • Homogeneous enhancement (CT contrast)
  • Hyperintense on in-phase and hypointense on oppose-phase (MRI)
Mix
Carcinoma
Nodular

Hyperplasia

Adrenal mass Clinical manifestations Diagnosis Gold standard Other features
Symptoms Signs Blood & Urine Histopathological Imaging Others

References